Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer

Title
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer
Authors
Keywords
Breast neoplasm, Exemestane, Metformin, Rosiglitazone, Phase I trial
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 1, Pages 63-72
Publisher
Springer Nature
Online
2012-09-28
DOI
10.1007/s00280-012-1977-9

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started